Toll-Like Receptor-Dependent Activation of Antigen-Presenting Cells Affects Adaptive Immunity to Helicobacter pylori

Gastroenterology

Volumn 133, Issue 1, 2007, Pages

  Rad, Roland ^a   Brenner, Lena ^a   Krug, Anne ^a   Voland, Petra ^a   Mages, Jörg ^b   Lang, Roland ^b   Schwendy, Susanne ^a   Reindl, Wolfgang ^a   Dossumbekova, Anar ^a   Ballhorn, Wibke ^a   Wagner, Hermann ^b   Schmid, Roland M ^a   Bauer, Stefan ^c   Prinz, Christian ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2C; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 18; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; CELL ACTIVATION; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; EFFECTOR CELL; GASTRITIS; GENE; HELICOBACTER PYLORI; HELPER CELL; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; UPREGULATION;

EID: 34447094822     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.04.071     Document Type: Article

References (58)

1. Marshall B.J., and Warren J.R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1 (1984) 1311-1315
2. Blaser M.J., and Atherton J.C. Helicobacter pylori persistence: biology and disease. J Clin Invest 113 (2004) 321-333
3. Monack D.M., Mueller A., and Falkow S. Persistent bacterial infections: the interface of the pathogen and the host immune system. Nat Rev Microbiol 2 (2004) 747-765
4. Suerbaum S., and Michetti P. Helicobacter pylori infection. N Engl J Med 347 (2002) 1175-1186
5. Peek Jr. R.M., and Blaser M.J. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2 (2002) 28-37
6. Ernst P.B., and Gold B.D. The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer. Annu Rev Microbiol 54 (2000) 615-640
7. Censini S., Lange C., Xiang Z., Crabtree J.E., Ghiara P., Borodovsky M., Rappuoli R., and Covacci A. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci U S A 93 (1996) 14648-14653
8. Guillemin K., Salama N.R., Tompkins L.S., and Falkow S. Cag pathogenicity island-specific responses of gastric epithelial cells to Helicobacter pylori infection. Proc Natl Acad Sci U S A 99 (2002) 15136-15141
9. Brandt S., Kwok T., Hartig R., Konig W., and Backert S. NF-kappaB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein. Proc Natl Acad Sci U S A 102 (2005) 9300-9305
10. Viala J., Chaput C., Boneca I.G., Cardona A., Girardin S.E., Moran A.P., Athman R., Memet S., Huerre M.R., Coyle A.J., DiStefano P.S., Sansonetti P.J., Labigne A., Bertin J., Philpott D.J., and Ferrero R.L. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol 5 (2004) 1166-1174
11. Kapsenberg M.L. Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol 3 (2003) 984-993
12. Janeway Jr. C.A., and Medzhitov R. Innate immune recognition. Annu Rev Immunol 20 (2002) 197-216
13. Akira S., and Takeda K. Toll-like receptor signalling. Nat Rev Immunol 4 (2004) 499-511
14. Bauer S., Kirschning C.J., Hacker H., Redecke V., Hausmann S., Akira S., Wagner H., and Lipford G.B. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc Natl Acad Sci U S A 98 (2001) 9237-9242
15. Heil F., Hemmi H., Hochrein H., Ampenberger F., Kirschning C., Akira S., Lipford G., Wagner H., and Bauer S. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303 (2004) 1526-1529
16. Iwasaki A., and Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 5 (2004) 987-995
17. Hochholzer P., Lipford G.B., Wagner H., Pfeffer K., and Heeg K. Role of interleukin-18 (IL-18) during lethal shock: decreased lipopolysaccharide sensitivity but normal superantigen reaction in IL-18-deficient mice. Infect Immun 68 (2000) 3502-3508
18. Rad R., Brenner L., Bauer S., Schwendy S., Layland L., da Costa C.P., Reindl W., Dossumbekova A., Friedrich M., Saur D., Wagner H., Schmid R.M., and Prinz C. CD25+/Foxp3+ T cells regulate gastric inflammation and Helicobacter pylori colonization in vivo. Gastroenterology 131 (2006) 525-537
19. Rad R., Gerhard M., Lang R., Schoniger M., Rosch T., Schepp W., Becker I., Wagner H., and Prinz C. The Helicobacter pylori blood group antigen-binding adhesin facilitates bacterial colonization and augments a nonspecific immune response. J Immunol 168 (2002) 3033-3041
20. Chaussabel D., and Sher A. Mining microarray expression data by literature profiling. Genome Biol 3 (2002) 0055.1-0055.15
21. Rescigno M., Urbano M., Valzasina B., Francolini M., Rotta G., Bonasio R., Granucci F., Kraehenbuhl J.P., and Ricciardi-Castagnoli P. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2 (2001) 361-367
22. Hoebe K., Janssen E.M., Kim S.O., Alexopoulou L., Flavell R.A., Han J., and Beutler B. Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways. Nat Immunol 4 (2003) 1223-1229
23. Agrawal S., Agrawal A., Doughty B., Gerwitz A., Blenis J., Van D.T., and Pulendran B. Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos. J Immunol 171 (2003) 4984-4989
24. Toellner K.M., Luther S.A., Sze D.M., Choy R.K., Taylor D.R., MacLennan I.C., and Cha-Orbea H. T helper 1 (Th1) and Th2 characteristics start to develop during T cell priming and are associated with an immediate ability to induce immunoglobulin class switching. J Exp Med 187 (1998) 1193-1204
25. Martin R.M., Brady J.L., and Lew A.M. The need for IgG2c specific antiserum when isotyping antibodies from C57BL/6 and NOD mice. J Immunol Methods 212 (1998) 187-192
26. Maeda S., Otsuka M., Hirata Y., Mitsuno Y., Yoshida H., Shiratori Y., Masuho Y., Muramatsu M., Seki N., and Omata M. cDNA microarray analysis of Helicobacter pylori-mediated alteration of gene expression in gastric cancer cells. Biochem Biophys Res Commun 284 (2001) 443-449
27. Huff J.L., Hansen L.M., and Solnick J.V. Gastric transcription profile of Helicobacter pylori infection in the rhesus macaque. Infect Immun 72 (2004) 5216-5226
28. Wen S., Felley C.P., Bouzourene H., Reimers M., Michetti P., and Pan-Hammarstrom Q. Inflammatory gene profiles in gastric mucosa during Helicobacter pylori infection in humans. J Immunol 172 (2004) 2595-2606
29. Scanga C.A., Aliberti J., Jankovic D., Tilloy F., Bennouna S., Denkers E.Y., Medzhitov R., and Sher A. Cutting edge: MyD88 is required for resistance to Toxoplasma gondii infection and regulates parasite-induced IL-12 production by dendritic cells. J Immunol 168 (2002) 5997-6001
30. Schnare M., Barton G.M., Holt A.C., Takeda K., Akira S., and Medzhitov R. Toll-like receptors control activation of adaptive immune responses. Nat Immunol 2 (2001) 947-950
31. Sun J., Walsh M., Villarino A.V., Cervi L., Hunter C.A., Choi Y., and Pearce E.J. TLR ligands can activate dendritic cells to provide a MyD88-dependent negative signal for Th2 cell development. J Immunol 174 (2005) 742-751
32. Amsen D., Blander J.M., Lee G.R., Tanigaki K., Honjo T., and Flavell R.A. Instruction of distinct CD4 T helper cell fates by different notch ligands on antigen-presenting cells. Cell 117 (2004) 515-526
33. Ishihara S., Rumi M.A., Kadowaki Y., Ortega-Cava C.F., Yuki T., Yoshino N., Miyaoka Y., Kazumori H., Ishimura N., Amano Y., and Kinoshita Y. Essential role of MD-2 in TLR4-dependent signaling during Helicobacter pylori-associated gastritis. J Immunol 173 (2004) 1406-1416
34. Kawahara T., Teshima S., Oka A., Sugiyama T., Kishi K., and Rokutan K. Type I Helicobacter pylori lipopolysaccharide stimulates toll-like receptor 4 and activates mitogen oxidase 1 in gastric pit cells. Infect Immun 69 (2001) 4382-4389
35. Maeda S., Akanuma M., Mitsuno Y., Hirata Y., Ogura K., Yoshida H., Shiratori Y., and Omata M. Distinct mechanism of Helicobacter pylori-mediated NF-kappa B activation between gastric cancer cells and monocytic cells. J Biol Chem 276 (2001) 44856-44864
36. Su B., Ceponis P.J., Lebel S., Huynh H., and Sherman P.M. Helicobacter pylori activates Toll-like receptor 4 expression in gastrointestinal epithelial cells. Infect Immun 71 (2003) 3496-3502
37. Backhed F., Rokbi B., Torstensson E., Zhao Y., Nilsson C., Seguin D., Normark S., Buchan A.M., and Richter-Dahlfors A. Gastric mucosal recognition of Helicobacter pylori is independent of Toll-like receptor 4. J Infect Dis 187 (2003) 829-836
38. Smith Jr. M.F., Mitchell A., Li G., Ding S., Fitzmaurice A.M., Ryan K., Crowe S., and Goldberg J.B. Toll-like receptor (TLR) 2 and TLR5, but not TLR4, are required for Helicobacter pylori-induced NF-kappa B activation and chemokine expression by epithelial cells. J Biol Chem 278 (2003) 32552-32560
39. Moran A.P., Lindner B., and Walsh E.J. Structural characterization of the lipid A component of Helicobacter pylori rough- and smooth-form lipopolysaccharides. J Bacteriol 179 (1997) 6453-6463
40. Pulendran B., Kumar P., Cutler C.W., Mohamadzadeh M., Van D.T., and Banchereau J. Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo. J Immunol 167 (2001) 5067-5076
41. Bliss Jr. C.M., Golenbock D.T., Keates S., Linevsky J.K., and Kelly C.P. Helicobacter pylori lipopolysaccharide binds to CD14 and stimulates release of interleukin-8, epithelial neutrophil-activating peptide 78, and monocyte chemotactic protein 1 by human monocytes. Infect Immun 66 (1998) 5357-5363
42. Schmitz F., Mages J., Heit A., Lang R., and Wagner H. Transcriptional activation induced in macrophages by Toll-like receptor (TLR) ligands: from expression profiling to a model of TLR signaling. Eur J Immunol 34 (2004) 2863-2873
43. Bjorkbacka H., Fitzgerald K.A., Huet F., Li X., Gregory J.A., Lee M.A., Ordija C.M., Dowley N.E., Golenbock D.T., and Freeman M.W. The induction of macrophage gene expression by LPS predominantly utilizes Myd88-independent signaling cascades. Physiol Genomics 19 (2004) 319-330
44. Andersen-Nissen E., Smith K.D., Strobe K.L., Barrett S.L., Cookson B.T., Logan S.M., and Aderem A. Evasion of Toll-like receptor 5 by flagellated bacteria. Proc Natl Acad Sci U S A 102 (2005) 9247-9252
45. Gewirtz A.T., Yu Y., Krishna U.S., Israel D.A., Lyons S.L., and Peek Jr. R.M. Helicobacter pylori flagellin evades toll-like receptor 5-mediated innate immunity. J Infect Dis 189 (2004) 1914-1920
46. Lee S.K., Stack A., Katzowitsch E., Aizawa S.I., Suerbaum S., and Josenhans C. Helicobacter pylori flagellins have very low intrinsic activity to stimulate human gastric epithelial cells via TLR5. Microbes Infect 5 (2003) 1345-1356
47. Mandell L., Moran A.P., Cocchiarella A., Houghton J., Taylor N., Fox J.G., Wang T.C., and Kurt-Jones E.A. Intact gram-negative Helicobacter pylori, Helicobacter felis, and Helicobacter hepaticus bacteria activate innate immunity via toll-like receptor 2 but not toll-like receptor 4. Infect Immun 72 (2004) 6446-6454
48. Amedei A., Cappon A., Codolo G., Cabrelle A., Polenghi A., Benagiano M., Tasca E., Azzurri A., D'Elios M.M., Del P.G., and de B.M. The neutrophil-activating protein of Helicobacter pylori promotes Th1 immune responses. J Clin Invest 116 (2006) 1092-1101
49. Ferrero R.L. Innate immune recognition of the extracellular mucosal pathogen, Helicobacter pylori. Mol Immunol 42 (2005) 879-885
50. Schmausser B., Andrulis M., Endrich S., Lee S.K., Josenhans C., Muller-Hermelink H.K., and Eck M. Expression and subcellular distribution of toll-like receptors TLR4, TLR5 and TLR9 on the gastric epithelium in Helicobacter pylori infection. Clin Exp Immunol 136 (2004) 521-526
51. Cario E., Brown D., McKee M., Lynch-Devaney K., Gerken G., and Podolsky D.K. Commensal-associated molecular patterns induce selective toll-like receptor-trafficking from apical membrane to cytoplasmic compartments in polarized intestinal epithelium. Am J Pathol 160 (2002) 165-173
52. Napolitani G., Rinaldi A., Bertoni F., Sallusto F., and Lanzavecchia A. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat Immunol 6 (2005) 769-776
53. Redecke V., Hacker H., Datta S.K., Fermin A., Pitha P.M., Broide D.H., and Raz E. Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J Immunol 172 (2004) 2739-2743
54. Dillon S., Agrawal A., Van D.T., Landreth G., McCauley L., Koh A., Maliszewski C., Akira S., and Pulendran B. A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells. J Immunol 172 (2004) 4733-4743
55. Pulendran B. Variegation of the immune response with dendritic cells and pathogen recognition receptors. J Immunol 174 (2005) 2457-2465
56. Panthel K., Faller G., and Haas R. Colonization of C57BL/6J and BALB/c wild-type and knockout mice with Helicobacter pylori: effect of vaccination and implications for innate and acquired immunity. Infect Immun 71 (2003) 794-800
57. Sakagami T., Vella J., Dixon M.F., O'Rourke J., Radcliff F., Sutton P., Shimoyama T., Beagley K., and Lee A. The endotoxin of Helicobacter pylori is a modulator of host-dependent gastritis. Infect Immun 65 (1997) 3310-3316
58. Ulevitch R.J. Therapeutics targeting the innate immune system. Nat Rev Immunol 4 (2004) 512-520